Safety study of vyvanse (Lisdexamfetamine Dimesylate) in ADHD
This study is completed in the United States. It is testing vyvanse (Lisdexamfetamine Dimesylate) for ADHD.
Multiple locations, including Scottsdale
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It is testing vyvanse (Lisdexamfetamine Dimesylate) for ADHD.
Multiple locations, including ScottsdaleThis study is completed. It focuses on PTSD and currently lists study information in the United States.
In BoulderThis study is completed in the United States. It is testing Double-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD.
Multiple locations, including AshevilleThis study was terminated in the United States. It focuses on Bipolarity.
In BethesdaThis study was withdrawn in Global. It focuses on ADHD.
In GlobalThis study is completed in the United States. It focuses on depression.
In ClevelandThis study is ongoing in the United Kingdom. It focuses on depression.
In United KingdomThis study is completed in the United States, in France, in the United Kingdom, .... It is testing LDX for ADHD.
Multiple locations, including Rolling Hills EstatesThis study is completed. It focuses on PTSD and currently lists study information in the United States.
In HoustonThis study has public registry information. It focuses on depression and currently lists study information in Italy.
In MilanThis study is completed. It focuses on bipolarity and currently lists study information in the United States.
In PittsburghThis study is completed. It focuses on PTSD and currently lists study information in the United States.
In CharlestonHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.